Pharma Focus Asia

Ferring Pharmaceuticals invests to integrate manufaturing operations in New Jersey

Introduction

Switzerland-based Ferring Pharmaceuticals to start manufacturing at its U.S. Operations Center.

Features

This new U.S. Operations Center is built on a 25-acre lot located at 100 Interpace Parkway in Parsippany, New Jersey. The company has invested $135 million(estimated) in an existing building, constructing offices, laboratories, a clinical-testing department.

New Facility will bring 275 new jobs to the local community. This Operation center will soon be manufacturing and shipping about $200 million(estimated) in product annually. The manufacturing of products at this center will gradually comes online over the course of the next 18 to 24 months(2016).

Specifications Table:

  • Company Name
  • Ferring Pharmaceuticals
  • Location
  • Parsippany, New Jersey
  • Type
  • Pharmaceutical Manufacturing Plant
  • Manufacturing Starting Year
  • 2016
  • Investment So Far
  • $135 million
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference